To study the efficacy of Vaman Karma and Shirishadi Avaleha in the management of Tamakshwas

Phase 2/3

Not yet recruiting

• Conditions: Moderate persistent asthma. Ayurveda Condition: TAMAKASVASAH,

• Registration Number: CTRI/2025/04/084455
• Lead Sponsor: LRP Ayurvedic Hospital and Research Centre

Brief Summary

Now a day’s most of the people facing of the Tamakshwas. It is well known for its recurrence & chronicity.Bronchial Asthma mentioned in modern medicine closely resembles with Tamakshwas.

Charak described lakshanas of Tamakshwas like Shwaskeichata, kaas, kanthodhvamsanam,asinolabhatesaukhyam, ghurghurikam. Shodhan procedure has given a due importance in this disease by almost all acharyas. Among shodhan, Vaman & Virechan is indicated in Tamakshwas. This disease is manifested by aggrevated pranavayu due to obstruction of kapha. Acharya in case of Tamakshwas advices Vaman.

The expression of bronchial asthma is influenced by the interaction between genetic,host & environmental factors.Apart from these there is going to be a large group of potential respiratory patients in future. They are person exposed to smoke, pollution & various types of occupational dust which are more prone to develop asthma & therefore constitute the group of potential respiratory patients.

Drugs having kapha-vatahar property are indicated for Vaman Karma . Drugs having kapha-vataghna,ushna & vatanuloman activities will prescribed for Shwas. Avaleha kalpana described in Sharandhar Madhyamkhand . So I choose Shirishadi Avaleha,in which drugs having properties like kapha-vataghna,vatanuloman & shwashar. Hence,the present study is planned.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-01-04
• Study Start: 2025-05-23

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 1.patient fulfilling classical lakshanas according to tamakshwas.
• 2.Irrespective of religion economical status occupation etc.
• 3.Vaman yogya patient.

Exclusion Criteria

1.uncontrolled DM and HTN 2.pregnant or lactating mother 3.HIV positive cases 4.patient suffering from any systemic disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the efficacy of vaman karma and shirishadi avaleha in the management of tamakshwas with special reference to Bronchial Ashtama.	48 days

Secondary Outcome Measures

Name	Time	Method
To reduce the lakshanas of tamakshwas in 48 days.	To study the literature related concept of tamakshwas.

Trial Locations

Locations (1)

LRP Ayurvedic Medical College and Hospital; 🇮🇳 Sangli, MAHARASHTRA, India

LRP Ayurvedic Medical College and Hospital

🇮🇳Sangli, MAHARASHTRA, India

Dr Gauri Sadashiv Belpatre

Principal investigator

7083105089

belpatregauri@gmail.com